Managers / Q1 2026
11.2 Capital Management, LLC
CIK 0002072160 · 1611 SPRING GATE LN, UNIT 371763, LAS VEGAS, NV, 89134 · 6508040697
Summary
11.2 Capital Management, LLC reported $143M in U.S.-listed holdings across 1 positions for Q1 2026.
The portfolio is heavily concentrated: HNGE alone accounts for 100.0% of reported value.
The book was largely unchanged from Q4 2025.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 100.0% · $143M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| HNGEHINGE HEALTH INC | HELD | +0 | 3.70M | −$29M | $143M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2026
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | HNGEHINGE HEALTH INChistory → | CL A | 100.00% | $143M | 3.70M |
Filing History
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.